Turning market telemetry into decisions for a pharmaceutical company in Costa Rica
A Costa Rican pharmaceutical company replaces market opacity with structured intelligence so commercial decisions rest on evidence rather than intuition.
The Situation
A pharmaceutical company in Costa Rica was making commercial decisions on fragmented, incomplete market signals, facing price commoditization and aggressive competitor discounting without a reliable view of market elasticity. Strategic choices about segments, pricing and positioning were being made on partial information, meaning each decision carried risk that was invisible until it showed up in the numbers. In a sector where misallocation and weak pricing compound over long product lifecycles, the absence of a structured market view was quietly taxing every commercial choice. The challenge was to build a structured view of demand, competition and opportunity so that strategic choices could be made with confidence rather than guesswork.
The Insight
Decisions made in the dark compound their cost across every downstream choice, and the pharmaceutical company's constraint was not a weak stage in its funnel but that its own market telemetry was unreadable. The economic logic is that exposure, attention and conversion can only be managed once the business can see them — so the highest-leverage move is to build visibility of demand, competition and elasticity first, converting a stream of uncoordinated guesses into a single evidence base from which every later decision is made with confidence.
Diagnosis
Read through Marketing Engineering™, the root constraint was X0 — Data Opacity: before exposure, attention or conversion could be managed, the organization simply lacked visibility into its own market telemetry. Decisions were happening in the dark.
CORE™ Maturity Diagnosis
Scale 1–7. Highlighted = the real constraint this diagnosis identified.
Framework applied: marketing-engineering
The Strategy
The decision was to replace opacity with evidence before making further strategic moves, and Evox Market Intelligence™ was the right program because it consolidates scattered signals into an organized view of the market. The strategy was to reverse-engineer competitor acquisition dynamics and map underserved, high-margin segments, so that demand could be sized, competition read and priorities set from evidence rather than intuition — buying clarity ahead of any further spend.
Execution
The engagement applied Evox Market Intelligence™ to replace opacity with an organized view of the market. The concrete work conducted deep competitive data mining and addressable market analysis, reverse-engineering competitor acquisition dynamics and mapping underserved customer segments to uncover margin vulnerabilities and willingness-to-pay — consolidating the signals that let leadership size demand, read competition and prioritize where to act.
The Investment
The engagement ran as an 8-month program in which the investment was intelligence itself: building the structured market view before acting on it. Its nature was decisive and evidence-first, with the company paying to shrink the uncertainty in its largest allocations rather than guessing at where effort and capital should go.
The Results
The Market Intelligence™ program conducted deep competitive data mining and addressable market analysis to uncover competitor margin vulnerabilities and buyer willingness-to-pay. Facing price commoditization under X0 · Data Opacity (telemetry breakdown and unverified conversion signals), the enterprise had lacked objective telemetry regarding market elasticity and competitor discounting practices. Evox reverse-engineered competitor acquisition dynamics and mapped underserved customer segments. Applying value-based tier restructuring and targeted differentiation expanded gross margins by 3.5 percentage points and increased direct competitive win rates to 46.8%. Over 8 months, the company captured an incremental 5.6 percentage points of market share, generating $2.10M in high-margin qualified commercial pipeline and validating that strategic market intelligence establishes enduring pricing power.
| Indicator | Result | Detail |
|---|---|---|
| Target Market Segment Share | +5.6 pp | Market share expansion achieved across defined high-margin commercial sub-sectors |
| Gross Product Margin Improvement | +3.5 pp | Margin expansion achieved through value-based pricing optimization and discounting governance |
| Strategic Opportunity Pipeline | $2.10M | Net commercial value added to pipeline following competitive positioning and tier-1 targeting |
| Competitive Win Rate | 46.8% | Direct head-to-head win rate against primary regional incumbents increased from 24.2% baseline |
Competitive Win Rate
Target Market Segment Share
Gross Product Margin Improvement
Strategic Opportunity Pipeline
Competitive Win Rate
Target Market Segment Share
Gross Product Margin Improvement
Strategic Opportunity Pipeline
The Exact Mechanism
Consolidating market telemetry and mapping underserved segments lifted the competitive win rate from 24.2% to 46.8%, expanded gross margin by 3.5 pp, captured 5.6 pp of market share and generated $2.10M in pipeline over 8 months.
Transferable Lessons
- Decisions made without visibility compound their cost across every downstream choice.
- In a commoditizing market, intelligence reveals where pricing power still exists before money is committed.
- One evidence base replaces many uncoordinated guesses with a single, defensible allocation logic.
- Mapping willingness-to-pay is the highest-leverage defense against aggressive competitor discounting.
Discussion Questions
- How much uncertainty is acceptable in major allocations before evidence becomes a prerequisite?
- When does defending margin through positioning beat competing directly on price?
- What is the earliest signal that a market view is sound enough to allocate against?